FIRST TRUST ADVISORS LP

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1125816 Wheaton, IL

Position in MIRM

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$13,974,507

+$3,097,584 QoQ

Shares Held

151,272

+9.9% QoQ

Ownership

0.248%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. MIRM ranks #27 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	346,855	$267,994,047
2	INCY	Incyte Corp	1,500,792	$141,254,543
3	VRTX	Vertex Pharmaceuticals Inc / Ma	306,461	$136,847,094
4	ALNY	Alnylam Pharmaceuticals, Inc.	382,701	$126,624,279
5	MRNA	Moderna, Inc.	2,392,693	$121,548,804
6	EXEL	Exelixis, Inc.	2,534,992	$108,725,806
7	AXSM	Axsome Therapeutics, Inc.	577,479	$97,605,500
8	HALO	Halozyme Therapeutics, Inc.	1,482,340	$95,803,634

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$13,974,507	151,272	+9.9%	Shares	Sole	2026-05-13
2025-12-31	$10,876,923	137,700	-4.5%	Shares	Sole	2026-02-13
2025-09-30	$10,574,820	144,248	+11.1%	Shares	Sole	2025-11-12
2025-06-30	$6,605,216	129,794	+0.1%	Shares	Sole	2025-08-13
2025-03-31	$5,840,011	129,634	-3.4%	Shares	Sole	2025-05-14
2024-12-31	$5,548,384	134,181	-8.4%	Shares	Sole	2025-02-13
2024-09-30	$5,710,029	146,411	+434.6%	Shares	Sole	2024-11-13
2024-06-30	$936,361	27,387	+143.1%	Shares	Sole	2024-08-13
2024-03-31	$282,976	11,265	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.